Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
It’s a COVID-19 special! We look at the greatest medicine making challenge the pharma industry has ever faced – the need to manufacture and deliver billions of doses to fight COVID-19 – by speaking with experts on access, distribution, packaging, and more. In NextGen, we also find out why serological testing is essential for COVID-19 surveillance and vaccine monitoring, and in Business, we ask if it’s time to onshore API supplies. Also in this issue, we cover the potential of treg cell therapy to transform autoimmune disease, multilayer tablets for patient-centric drug delivery, technology transfer, and how Russian dumplings inspired a new approach to drug delivery.